Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Levi Strauss & Co. (LEVI) vs Tilray Brands Inc (TLRY) Price & Performance

Levi Strauss & Co.Trade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Levi Strauss & Co. vs Tilray Brands Inc — how do they compare? Levi Strauss & Co. trades at $24.59 (market cap $9.21B), while Tilray Brands Inc trades at $4.25 (market cap $524.07M). The key difference: Levi Strauss & Co. is far larger — about 17.6× Tilray Brands Inc's market cap, and Levi Strauss & Co. pays a 2.68% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

LEVITLRY
Market Cap
$9.21B$524.07M
Sector
Consumer CyclicalHealth
52-Week High
$24.99$21.00
52-Week Low
$17.92$4.23
Enterprise Value
$10.52B$621.22M
Dividend Yield
2.68%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Levi Strauss & Co.

No Aura AI signal available yet.

Tilray Brands Inc

TLRY trades at $4.23, down 1.63% with bearish technical signals. The company reported revenue growth to $821.31M in 2025 but faces severe profitability challenges with a net loss of $2.19B and negative margins. Recent expansion includes medical cannabis launches in Panama and strategic acquisitions, while analyst consensus shows cautious sentiment with 65% hold ratings.

The outlook remains challenging due to persistent losses and high debt levels, though expansion initiatives and potential regulatory changes offer long-term opportunities. Key risks include execution on profitability, competitive pressures, and cannabis regulatory uncertainty.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Levi Strauss & Co.

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver

Read more on LEVI

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY